Sergey Young is the Founder of the Longevity Vision Fund, a $100M investment fund dedicated to making longevity affordable and accessible to all.
He is also the author of the book The Science and Technology of Growing Young, which serves as a map of the longevity space which is seeking to extend our lifespans.
Imagine a world where aging has become a disease that can be treated, allowing people to live as long as 150 or 200 instead of 70 or 80.
This is the vision that longevity scientists, entrepreneurs and investors are painting and whatever your perspective, it’s certainly a compelling one.
I previously spoke to Aubrey de Grey, founder of the SENS research project, in this episode if you’re looking for a primer on the science of longevity.
In this episode we discuss:
- How using health data will eventually enable us to reverse aging
- The current state of aging research and progress made in recent years
- The simple things we can all do to extend our lifespans and stay healthy
We also cover the different companies doing great work in the longevity space, the mentors that have inspired Sergey and the Longevity X Prize he’s launching.
This episode will give you a broad overview of the longevity field as well as some unique insights into what we can all do to live longer, healthier lives.
- Introducing Sergey [00:33]
- What could life look like if humans were able to live as long as 200 years and beyond? [02:14]
- What were Sergey’s takeaways from his conversation with Lord of the Rings director, Peter Jackson, on longevity and human avatars? [08:35]
- Why has Sergey dedicated his life and his research to longevity and healthcare? [10:43]
- What are the scientific hallmarks of aging? [17:08]
- What are some of today’s most important theses around the aging process? [19:05]
- How does Sergey maintain and monitor his health? How can we use our health data in making better health decisions? [31:59]
- Is there a difference between how Sergey approaches longevity as an investor versus as a researcher? [39:33]
- What is the government’s current role in the field of longevity? [43:44]
- Why is there less capital being invested into longevity research compared to other diseases? [45:33]
- What does XPPRIZE do and what innovations are they developing in the longevity field? [49:45]
- Has the profile of a Longevity Vision Fund investor changed over the years, with the field entering more mainstream conversations? [53:33]
- How does Sergey assess investments in longevity research? What makes an investment viable in longevity? [58:34]
- Why Sergey believes that all investments into longevity research are meaningful [01:00:04]
- Closing remarks [01:02:19]
Follow Sergey online